Amperos vs Penguin Ai

Penguin Ai is a platform sold to payers and providers. Its about page lists Intelligent UM for payer prior authorization, HCC Coding & Risk Adjustment and Intelligent RCM, the last described as pre-submission review and denial recovery in one loop, and it calls its output a recommendation, not a decision. Founded in 2024 in Palo Alto, it announced US$29.7M in funding on September 11, 2025, including a US$25M Series A led by Greycroft. The homepage figures, among them 10 million+ transactions and 96% accuracy across deployed AI Workers, are the vendor's, with no baseline cited.

Amperos's press release has its agents working denied claims through payer portals, and the vendor says its customer DOCS Dermatology Group recovered 24% more claims.

A payer's utilization management team buys Penguin Ai's UM product. A hospital RCM team on Epic FHIR or Cerner, the two EHR connections the about page names, that wants pre-submission review and denial recovery from one vendor fits Intelligent RCM. A dermatology group with a queue of denied claims fits Amperos.